Literature DB >> 15185142

Use of in vitro cytoadherence assays in the comparative study of the virulence of isolates of Trichomonas vaginalis.

Lázara Rojas1, Idalia Sariego, Jorge Fraga, Carlos A Sarría, Jorge Sarracent, Lizet Sánchez.   

Abstract

This study describes the use of bromo-deoxiuridine, a non-radioactive analogue of thymidine, to determine the adhesion of 40 T. vaginalis isolates, as compared with the clinical manifestations found in patients. Parasite-labeling was optimized and label detection by immunoassay was carried out. Bromo-deoxiuridine at 10 microM for 16 h produced the highest sensitivity. Once optimized, the assay was able to detect between 3.12 x 10(3) and 4 x 10(5) parasites, with a detection limit of 9.14 x 10(2), which is lower than with the use of [3H]-thymidine. The variation coefficients were 2.65% for repeatability and 3.8% for reproducibility. A correlation coefficient of 0.97 was found between the pattern curves obtained by both labeling procedures. The level of adhesion to HeLa cells was directly proportional to the severity of the clinical manifestations (P < 0.05). Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185142     DOI: 10.1007/s00436-004-1135-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  20 in total

Review 1.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells.

Authors:  R Arroyo; J F Alderete
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

3.  [Evaluation of the virulence of Trichomonas vaginalis strains by the study of their cytopathogenic effect on cultured cells].

Authors:  P Brasseur; J Savel
Journal:  C R Seances Soc Biol Fil       Date:  1982

4.  Association of production of cell-detaching factor with the clinical presentation of Trichomonas vaginalis.

Authors:  G E Garber; L T Lemchuk-Favel
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

5.  The effect of Trichomonas vaginalis and the role of pH on cell culture monolayer viability.

Authors:  G E Garber; W R Bowie
Journal:  Clin Invest Med       Date:  1990-04       Impact factor: 0.825

6.  Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro.

Authors:  R O Gilbert; G Elia; D H Beach; S Klaessig; B N Singh
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Characteristics of Trichomonas vaginalis isolates from women with and without colpitis macularis.

Authors:  J N Krieger; P Wolner-Hanssen; C Stevens; K K Holmes
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

8.  Detection of mammalian carcinogens with an immunological DNA synthesis-inhibition test.

Authors:  J Heil; G Reifferscheid
Journal:  Carcinogenesis       Date:  1992-12       Impact factor: 4.944

9.  Nucleoside uptake by Trichomonas vaginalis.

Authors:  D I Harris; R B Beechey; D Linstead; J Barrett
Journal:  Mol Biochem Parasitol       Date:  1988-06       Impact factor: 1.759

10.  Identification and properties of Trichomonas vaginalis proteins involved in cytadherence.

Authors:  J F Alderete; G E Garza
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  2 in total

1.  Novel trichomonacidal spermicides.

Authors:  Ashish Jain; Nand Lal; Lokesh Kumar; Vikas Verma; Rajeev Kumar; Lalit Kumar; Vishal Singh; Raghav K Mishra; Amit Sarswat; S K Jain; J P Maikhuri; V L Sharma; Gopal Gupta
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

2.  Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7.

Authors:  Zhaona Wu; Haris Mirza; Kevin Shyong Wei Tan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.